ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
The Italian Trade Agency (ITA) and the Ministry of Foreign Affairs will host the eighth 'Italy on the Move' event alongside the 43rd J.P. Morgan Healthcare Conference 2025 in San Francisco. The event, scheduled for January 15, 2025, at INNOVIT, aims to showcase Italy's €270 billion life sciences sector and investment opportunities.
The Italian life sciences ecosystem, contributing 11% to the country's GDP, has attracted nearly 50 multinational companies. Italy ranks first among EU economies in pharma CDMO manufacturing value and fourth worldwide in Life Sciences patents productivity.
The event will feature keynote speakers including Ambassador Mariangela Zappia and Director General Mauro Battocchi, followed by a panel discussion on 'Navigating Transatlantic Partnerships in Life Sciences' moderated by Audrey Greenberg. Notable panelists include executives from Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, and Genenta Science (NASDAQ: GNTA). Five Italian startups - Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech - will present pitch presentations.
L'Agenzia Italiana per il Commercio Estero (ITA) e il Ministero degli Affari Esteri ospiteranno l'ottavo evento 'Italy on the Move' in concomitanza con il 43° J.P. Morgan Healthcare Conference 2025 a San Francisco. L'evento, previsto per il 15 gennaio 2025, presso INNOVIT, ha l'obiettivo di mettere in luce il settore delle scienze della vita italiano, del valore di 270 miliardi di euro, e le opportunità di investimento.
Il sistema delle scienze della vita italiano, che contribuisce per l'11% al PIL del paese, ha attirato quasi 50 multinazionali. L'Italia si colloca al primo posto tra le economie dell'UE per valore di produzione nel settore CDMO farmaceutico e al quarto posto a livello mondiale per produttività di brevetti nelle scienze della vita.
All'evento parteciperanno relatori di spicco, tra cui l'Ambasciatore Mariangela Zappia e il Direttore Generale Mauro Battocchi, seguiti da una tavola rotonda dal titolo 'Navigare le Partnership Transatlantiche nelle Scienze della Vita', moderata da Audrey Greenberg. Tra i relatori ci saranno dirigenti di Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, e Genenta Science (NASDAQ: GNTA). Cinque startup italiane - Aavantgarde, Butterfly Decisions, Cellply, Medlea e Sibylla Biotech - presenteranno le loro pitch.
La Agencia Italiana de Comercio (ITA) y el Ministerio de Asuntos Exteriores albergarán el octavo evento 'Italia en Movimiento' junto a la 43ª Conferencia de Salud de J.P. Morgan 2025 en San Francisco. El evento, programado para el 15 de enero de 2025, en INNOVIT, tiene como objetivo mostrar el sector de las ciencias de la vida de Italia, que tiene un valor de 270 mil millones de euros, y las oportunidades de inversión.
El ecosistema italiano de ciencias de la vida, que contribuye con el 11% al PIB del país, ha atraído a casi 50 empresas multinacionales. Italia ocupa el primer lugar entre las economías de la UE en valor de fabricación de CDMO farmacéutico y el cuarto lugar en el mundo en productividad de patentes de ciencias de la vida.
En el evento habrá ponentes destacados, incluidos la Embajadora Mariangela Zappia y el Director General Mauro Battocchi, seguidos de una mesa redonda sobre 'Navegando las Asociaciones Transatlánticas en Ciencias de la Vida', moderada por Audrey Greenberg. Entre los panelistas se encuentran ejecutivos de Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, y Genenta Science (NASDAQ: GNTA). Cinco startups italianas - Aavantgarde, Butterfly Decisions, Cellply, Medlea y Sibylla Biotech - harán presentaciones.
이탈리아 대외 무역청(ITA)와 외교부는 2025년 1월 15일 샌프란시스코의 INNOVIT에서 열리는 제43회 J.P. 모건 헬스케어 컨퍼런스와 함께 제8회 '이탈리아 온 더 무브' 이벤트를 주최합니다. 이 행사는 2700억 유로 규모의 이탈리아 생명과학 부문과 투자 기회를 소개하는 것을 목표로 하고 있습니다.
이탈리아의 생명과학 생태계는 국내 총생산(GDP)의 11%를 기여하며, 거의 50개의 다국적 기업을 유치했습니다. 이탈리아는 EU 경제 중 제약 CDMO 제조 가치에서 1위, 생명과학 특허 생산성에서 세계 4위를 차지하고 있습니다.
행사에는 마리안젤라 자피아 대사와 마우로 바토키 총장 등 주요 연사들이 참석하며, 오드리 그린버그가 진행하는 '생명과학에서의 대서양 파트너십 탐색'에 대한 패널 토론이 이어집니다. 패널리스트로는 Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital의 임원들이 포함되며, 제넨타 사이언스 (NASDAQ: GNTA)도 참여합니다. 다섯 개의 이탈리아 스타트업(Aavantgarde, Butterfly Decisions, Cellply, Medlea, Sibylla Biotech)이 발표를 진행할 예정입니다.
L'Agence Italienne de Commerce (ITA) et le Ministère des Affaires Étrangères organiseront le huitième événement 'L'Italie en Mouvement' en marge de la 43e Conférence de la Santé J.P. Morgan 2025 à San Francisco. L'événement, prévu le 15 janvier 2025 à INNOVIT, a pour but de mettre en avant le secteur des sciences de la vie en Italie, d'une valeur de 270 milliards d'euros, ainsi que les opportunités d'investissement.
L'écosystème italien des sciences de la vie, qui contribue à hauteur de 11% au PIB du pays, a attiré près de 50 entreprises multinationales. L'Italie se classe au premier rang parmi les économies de l'UE en valeur de fabrication CDMO pharmaceutique et au quatrième rang mondial en termes de productivité des brevets dans les sciences de la vie.
L'événement mettra en vedette des intervenants de premier plan, y compris l'Ambassadrice Mariangela Zappia et le Directeur Général Mauro Battocchi, suivis d'une table ronde sur 'Naviguer dans les Partenariats Transatlantiques dans les Sciences de la Vie', animée par Audrey Greenberg. Parmi les participants notables, on compte des dirigeants de Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, et Genenta Science (NASDAQ: GNTA). Cinq startups italiennes - Aavantgarde, Butterfly Decisions, Cellply, Medlea et Sibylla Biotech - feront des présentations de pitch.
Die Italienische Handelsagentur (ITA) und das Ministerium für Auswärtige Angelegenheiten veranstalten die achte Veranstaltung 'Italien in Bewegung' anlässlich der 43. J.P. Morgan Healthcare Conference 2025 in San Francisco. Die Veranstaltung, die für den 15. Januar 2025 im INNOVIT geplant ist, zielt darauf ab, den italienischen Lebenswissenschaftssektor im Wert von 270 Milliarden Euro und die Investitionsmöglichkeiten vorzustellen.
Das italienische Ökosystem der Lebenswissenschaften, das 11% zum BIP des Landes beiträgt, hat fast 50 multinationale Unternehmen angezogen. Italien belegt den ersten Platz unter den EU-Wirtschaften im Wert der pharmazeutischen CDMO-Produktion und den vierten Platz weltweit in der Produktivität von Patenten in den Lebenswissenschaften.
Die Veranstaltung wird herausragende Redner wie Botschafterin Mariangela Zappia und Generaldirektor Mauro Battocchi umfassen, gefolgt von einer Podiumsdiskussion zum Thema 'Navigieren in transatlantischen Partnerschaften in den Lebenswissenschaften', die von Audrey Greenberg moderiert wird. Zu den bemerkenswerten Podiumsteilnehmern gehören Führungskräfte von Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital und Genenta Science (NASDAQ: GNTA). Fünf italienische Startups - Aavantgarde, Butterfly Decisions, Cellply, Medlea und Sibylla Biotech - werden Pitch-Präsentationen halten.
- None.
- None.
Event showcases
Opening remarks at the event will be from the Ambassador of
The Italian life sciences ecosystem overview will be provided by Keynote Speaker Mauro Battocchi, the Director General for the Promotion of the Italy System at the Italian Ministry of Foreign Affairs and International Cooperation, who noted, "With a turnover of
Ambassador Zappia said, "
Consul General Strozzi emphasized, "
"Since 2016, Italy on the Move has been the annual appointment with the Italian life sciences industry in
The event will also include a panel discussion, "Navigating Transatlantic Partnerships in Life Sciences," moderated by Audrey Greenberg, Founder of the Center for Breakthrough Medicines and CEO and Founder of AG Capital Advisors.
Panelists include leading life sciences executives:
- Frederick Beddingfield - CEO, Rubedo Life Sciences
- Fulvio Renoldi Bracco - CEO, Bracco Imaging
- Elcin Barker Ergun - CEO and Member of the Board, Menarini Group
- Karthic Jayaraman - Partner and Co-Head of Global Healthcare, TPG Capital
- Pierluigi Paracchi - CEO, Co-Founder and Chairman, Genenta Science (Nasdaq: GNTA)
- Maria Cristina Porta - General Director, ENEA Tech and Biomedical
- Riccardo Zagaria - CEO, DOC Pharma
In addition, five key Italian startups will provide pitch presentations, specifically Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech.
About the Italian Trade Agency
The Italian Trade Agency is the government agency which promotes the globalization of Italian firms under the aegis of the Ministry of Foreign Affairs. ITA helps to develop, facilitate and promote Italian economic and trade relations with foreign countries, focusing on the needs of SMEs, their associations and partnerships. ITA sustains Italian firms in their internationalization process, promoting the marketing of Italian goods and services as well as the image of "Made in
LinkedIn: https://www.linkedin.com/company/italosangeles/
Twitter: https://twitter.com/ITALosAngeles
Facebook: https://www.facebook.com/italosangeles
About INNOVIT
The Italian Innovation and Culture Hub INNOVIT is a strategic initiative of the Italian Government for the promotion of the Country System's innovation in
Web: innovitsf.com
LinkedIn: innovitsf
Media Contact for Event Queries and Attendance
Peter Collins
p.collins@togorun.com
908-499-1200
__________________________
1 Assolombarda. (2024, July). La rilevanza della filiera Life Science in Lombardia https://www.assolombarda.it/centro-studi/la-rilevanza-della-filiera-life-science-in-lombardia-edizione-2024 Accessed 1 January 2024.
2 https://www.investinitaly.gov.it/en/sectors/life-sciences
View original content to download multimedia:https://www.prnewswire.com/news-releases/italian-trade-agency-to-host-italy-on-the-move-2025-side-event-during-jp-morgan-healthcare-conference-302346296.html
SOURCE Italian Trade Agency
FAQ
What is the value of Italy's life sciences sector in 2025?
When and where is Italy on the Move 2025 taking place?
Which major companies are participating in the Italy on the Move 2025 panel discussion?
What is Italy's ranking in pharma CDMO manufacturing within the EU?
Which Italian startups will be pitching at Italy on the Move 2025?
How many life science multinationals have established operations in Italy?
